Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement | Zendy

Gulraj S. Matharu | Zendy; Setor K. Kunutsor | Zendy; Andrew Judge | Zendy; Ashley Blom | Zendy; Michael R. Whitehouse | Zendy

Open Access

Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement

Author(s) -

Gulraj S. Matharu,

Setor K. Kunutsor,

Andrew Judge,

Ashley Blom,

Michael R. Whitehouse

Publication year - 2020

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2019.6108

Subject(s) - medicine , knee replacement , aspirin , randomized controlled trial , arthroplasty , rivaroxaban , warfarin , hip replacement , population , pulmonary embolism , cochrane library , placebo , observational study , venous thrombosis , medline , deep vein , surgery , thrombosis , atrial fibrillation , alternative medicine , environmental health , pathology , political science , law

Patients undergoing total hip replacement (THR) and total knee replacement (TKR) receive venous thromboembolism (VTE) pharmacoprophylaxis. It is unclear which anticoagulant is preferable. Observational data suggest aspirin provides effective VTE prophylaxis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research